These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 9168236

  • 1. The in vitro anti-HIV efficacy of negatively charged human serum albumin is antagonized by heparin.
    Swart PJ, Sun CS, Kuipers ME, Asuncion C, Josephs S, Smit C, Meijer DK.
    AIDS Res Hum Retroviruses; 1997 May 20; 13(8):677-83. PubMed ID: 9168236
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of anti-HIV activity of succinylated human serum albumin.
    Kuipers ME, vd Berg M, Swart PJ, Laman JD, Meijer DK, Koppelman MH, Huisman H.
    Biochem Pharmacol; 1999 Apr 15; 57(8):889-98. PubMed ID: 10086322
    [Abstract] [Full Text] [Related]

  • 3. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW, Schols D, Pauwels R, De Clercq E, Meijer DK.
    Mol Pharmacol; 1993 Nov 15; 44(5):1003-7. PubMed ID: 7902528
    [Abstract] [Full Text] [Related]

  • 4. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.
    Cabrera C, Witvrouw M, Gutiérrez A, Clotet B, Kuipers ME, Swart PJ, Meijer DK, Desmyter J, De Clercq E, Esté JA.
    AIDS Res Hum Retroviruses; 1999 Nov 20; 15(17):1535-43. PubMed ID: 10580404
    [Abstract] [Full Text] [Related]

  • 5. The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins.
    Beljaars L, Floris R, Berkhout B, Smit C, Meijer DK, Molema G.
    Biochem Pharmacol; 2002 May 01; 63(9):1663-73. PubMed ID: 12007569
    [Abstract] [Full Text] [Related]

  • 6. A phase I/IIa study with succinylated human serum albumin (Suc-HSA), a candidate HIV-1 fusion inhibitor.
    Vermeulen JN, Meijer DK, Over J, Lange J, Proost JH, Bakker HI, Beljaars L, Wit FW, Prins JM.
    Antivir Ther; 2007 May 01; 12(2):273-8. PubMed ID: 17503670
    [Abstract] [Full Text] [Related]

  • 7. Potent inhibition of replication of primary HIV type 1 isolates in peripheral blood lymphocytes by negatively charged human serum albumins.
    Groenink M, Swart PJ, Broersen S, Kuipers M, Meijer DK, Schuitemaker H.
    AIDS Res Hum Retroviruses; 1997 Jan 20; 13(2):179-85. PubMed ID: 9007203
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice.
    Kuipers ME, Swart PJ, Schutten M, Smit C, Proost JH, Osterhaus AD, Meijer DK.
    Antiviral Res; 1997 Jan 20; 33(2):99-108. PubMed ID: 9021051
    [Abstract] [Full Text] [Related]

  • 9. Anti-HIV-1 activity of combinations and covalent conjugates of negatively charged human serum albumins (NCAs) and AZT.
    Kuipers ME, Swart PJ, Witvrouw M, Esté JA, Reymen D, De Clercq E, Meijer DK.
    J Drug Target; 1999 Jan 20; 6(5):323-35. PubMed ID: 10342381
    [Abstract] [Full Text] [Related]

  • 10. The metabolic fate of the Anti-HIV active drug carrier succinylated human serum albumin after intravenous administration in rats.
    Swart PJ, Kuipers ME, Smit C, Beljaars L, Ter Wiel J, Meijer DK.
    J Drug Target; 2001 Apr 20; 9(2):95-109. PubMed ID: 11697111
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
    Jansen RW, Molema G, Pauwels R, Schols D, De Clercq E, Meijer DK.
    Mol Pharmacol; 1991 Jun 20; 39(6):818-23. PubMed ID: 2051994
    [Abstract] [Full Text] [Related]

  • 13. Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA.
    Swart PJ, Beljaars E, Smit C, Pasma A, Schuitemaker H, Meijer DK.
    J Drug Target; 1996 Jun 20; 4(2):109-16. PubMed ID: 8894971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The amino-terminal peptide of HIV-1 gp41 interacts with human serum albumin.
    Gordon LM, Curtain CC, McCloyn V, Kirkpatrick A, Mobley PW, Waring AJ.
    AIDS Res Hum Retroviruses; 1993 Nov 20; 9(11):1145-56. PubMed ID: 8312056
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.
    Bugatti A, Urbinati C, Ravelli C, De Clercq E, Liekens S, Rusnati M.
    Antimicrob Agents Chemother; 2007 Jul 20; 51(7):2337-45. PubMed ID: 17452490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.